×

Biotech Stocks Facing FDA Decision In October 2021

Published Sep 30 2021 at 6:58 AM GMT
Key
Points
  • (RTTNews) - As we head into the fourth quarter of 2021, here is a recap of what happened on the regulatory front this month that caught our attention.
  • Samsung Bioepis' Byooviz became the first biosimilar for Lucentis to treat macular degeneration disease and other eye conditions, following its FDA approval on September 17.




Trending

Stats

  • Published Sep 30, 2021 6:58 AM GMT